• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各种介入放射学程序有效剂量转换系数的计算。

Calculation of conversion factors for effective dose for various interventional radiology procedures.

机构信息

Medical Physics Department, S. Orsola-Malpighi University Hospital, Bologna, Italy.

出版信息

Med Phys. 2012 May;39(5):2491-8. doi: 10.1118/1.3702457.

DOI:10.1118/1.3702457
PMID:22559619
Abstract

PURPOSE

To provide dose-area-product (DAP) to effective dose (E) conversion factors for complete interventional procedures, based on in-the-field clinical measurements of DAP values and using tabulated E/DAP conversion factors for single projections available from the literature.

METHODS

Nine types of interventional procedures were performed on 84 patients with two angiographic systems. Different calibration curves (with and without patient table attenuation) were calculated for each DAP meter. Clinical and dosimetric parameters were recorded in-the-field for each projection and for all patients, and a conversion factor linking DAP and effective doses was derived for each complete procedure making use of published, Monte Carlo calculated conversion factors for single static projections.

RESULTS

Fluoroscopy time and DAP values for the lowest-dose procedure (biliary drainage) were approximately 3-fold and 13-fold lower, respectively, than those for the highest-dose examination (transjugular intrahepatic portosystemic shunt, TIPS). Median E/DAP conversion factors from 0.12 (abdominal percutaneous transluminal angioplasty) to 0.25 (Nephrostomy) mSvGy(-1) cm(-2) were obtained and good correlations between E and DAP were found for all procedures, with R(2) coefficients ranging from 0.80 (abdominal angiography) to 0.99 (biliary stent insertion, Nephrostomy and TIPS). The DAP values obtained in this study showed general consistency with the values provided in the literature and median E values ranged from 4.0 mSv (biliary drainage) to 49.6 mSv (TIPS).

CONCLUSIONS

Values of E/DAP conversion factors were derived for each procedure from a comprehensive analysis of projection and dosimetric data: they could provide a good evaluation for the stochastic effects. These results can be obtained by means of a close cooperation between different interventional professionals involved in patient care and dose optimization.

摘要

目的

提供基于临床现场剂量面积乘积(DAP)值测量并利用文献中提供的单投影 E/DAP 转换因子表格,为所有介入操作提供 E/DAP 转换因子。

方法

对 84 名患者的 9 种介入操作,在两种血管造影系统上进行。为每个 DAP 剂量仪计算不同的校准曲线(带和不带患者台衰减)。对每个投影和所有患者,现场记录临床和剂量学参数,并利用文献中单静态投影计算的蒙特卡罗转换因子,为每个完整操作推导一个将 DAP 与有效剂量联系起来的转换因子。

结果

最低剂量操作(胆道引流)的透视时间和 DAP 值分别约为最高剂量检查(经颈静脉肝内门体分流术,TIPS)的 3 倍和 13 倍。获得了从 0.12(腹部经皮腔内血管成形术)到 0.25(经皮肾造瘘术)mSvGy(-1) cm(-2)的中位数 E/DAP 转换因子,并且对于所有操作都发现 E 与 DAP 之间存在良好的相关性,R(2) 系数范围从 0.80(腹部血管造影术)到 0.99(胆道支架植入术、经皮肾造瘘术和 TIPS)。本研究中获得的 DAP 值与文献中提供的值总体上一致,中位数 E 值范围从 4.0 mSv(胆道引流)到 49.6 mSv(TIPS)。

结论

从投影和剂量学数据的综合分析中为每个操作推导了 E/DAP 转换因子的值:它们可以对随机效应进行很好的评估。这些结果可以通过不同介入专业人员之间的密切合作来获得,以参与患者护理和剂量优化。

相似文献

1
Calculation of conversion factors for effective dose for various interventional radiology procedures.各种介入放射学程序有效剂量转换系数的计算。
Med Phys. 2012 May;39(5):2491-8. doi: 10.1118/1.3702457.
2
Effective and equivalent organ doses in patients undergoing coronary angiography and percutaneous coronary intervention.行冠状动脉造影及经皮冠状动脉介入术患者的有效且相当的器官剂量。
Med Phys. 2011 Apr;38(4):2168-75. doi: 10.1118/1.3561508.
3
Patient radiation doses and references levels in interventional radiology.介入放射学中的患者辐射剂量及参考水平。
Radiol Med. 2004 Apr;107(4):408-18.
4
Method of patient dose evaluation in the angiographic and interventional radiology procedures.血管造影和介入放射学程序中患者剂量评估的方法。
Radiol Med. 2005 Nov-Dec;110(5-6):689-98.
5
[Evaluation of patient doses in interventional radiology].[介入放射学中患者剂量的评估]
Radiol Med. 2001 Nov-Dec;102(5-6):384-90.
6
A study of the correlation between dose area product and effective dose in vascular radiology.血管放射学中剂量面积乘积与有效剂量之间的相关性研究。
Radiat Prot Dosimetry. 2008;130(3):300-8. doi: 10.1093/rpd/ncn050. Epub 2008 Feb 29.
7
Patient doses and dosimetric evaluations in interventional cardiology.介入心脏病学中的患者剂量与剂量学评估。
Phys Med. 2009 Mar;25(1):31-42. doi: 10.1016/j.ejmp.2008.03.002. Epub 2008 Apr 25.
8
A study of patient radiation doses in interventional radiological procedures.介入放射学程序中患者辐射剂量的研究。
Br J Radiol. 1998 Feb;71(842):175-85. doi: 10.1259/bjr.71.842.9579182.
9
Skin entrance radiation dose in an interventional radiology procedure.介入放射学程序中的皮肤入口辐射剂量。
Health Phys. 2006 Jul;91(1):41-6. doi: 10.1097/01.HP.0000198784.94210.1f.
10
Estimation of effective dose in some digital angiographic and interventional procedures.一些数字血管造影和介入手术中有效剂量的估算。
Br J Radiol. 1998 Jan;71(841):42-7. doi: 10.1259/bjr.71.841.9534698.

引用本文的文献

1
Hybrid-3D robotic suite in spine and trauma surgery - experiences in 210 patients.脊柱和创伤手术中的混合 3D 机器人套件 - 210 例患者的经验。
J Orthop Surg Res. 2024 Sep 14;19(1):565. doi: 10.1186/s13018-024-05044-9.
2
Determinants of radiation exposure during mobile cone-beam CT-guided robotic-assisted bronchoscopy.移动锥形束 CT 引导的机器人辅助支气管镜检查期间辐射暴露的决定因素。
Respirology. 2024 Sep;29(9):803-814. doi: 10.1111/resp.14765. Epub 2024 May 28.
3
Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C).
Y90 放射性栓塞治疗巴塞罗那临床肝癌分期 C(BCLC-C)肝癌患者的总生存和毒性。
BMC Gastroenterol. 2022 Nov 17;22(1):467. doi: 10.1186/s12876-022-02528-y.
4
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?肝细胞癌监测患者中未明确结节的肝活检可行性:活检真的是一种有用的工具吗?
J Clin Med. 2022 Jul 28;11(15):4399. doi: 10.3390/jcm11154399.
5
State-of-the-art review on the correlations between pathological and magnetic resonance features of cirrhotic nodules.肝硬化结节的病理与磁共振特征相关性的最新研究进展综述。
Histol Histopathol. 2022 Dec;37(12):1151-1165. doi: 10.14670/HH-18-487. Epub 2022 Jun 30.
6
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers.肝硬化肝脏中肝细胞癌的节段性分布
Diagnostics (Basel). 2022 Mar 29;12(4):834. doi: 10.3390/diagnostics12040834.
7
Rim Enhancement after Technically Successful Transarterial Chemoembolization in Hepatocellular Carcinoma: A Potential Mimic of Incomplete Embolization or Reactive Hyperemia?经导管肝动脉化疗栓塞术后肿瘤环形强化:不完全栓塞或反应性充血的潜在假象?
Tomography. 2022 Apr 15;8(2):1148-1158. doi: 10.3390/tomography8020094.
8
Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination.阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌的疗效观察
BMC Cancer. 2022 Mar 27;22(1):335. doi: 10.1186/s12885-022-09451-1.
9
Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization.白蛋白-胆红素评分的动态变化是接受经动脉化疗栓塞术的慢性丙型肝炎-肝细胞癌患者预后的良好预测指标。
Diagnostics (Basel). 2022 Mar 9;12(3):665. doi: 10.3390/diagnostics12030665.
10
Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.多参数 MRI 和放射组学在经导管动脉化疗栓塞联合仑伐替尼治疗后进展期不可切除肝细胞癌进展中的预后价值。
BMC Gastroenterol. 2022 Mar 8;22(1):108. doi: 10.1186/s12876-022-02129-9.